NZ212492A - Epoxy steroids with spiro-heterocyclic ring and pharmaceutical compositons - Google Patents

Epoxy steroids with spiro-heterocyclic ring and pharmaceutical compositons

Info

Publication number
NZ212492A
NZ212492A NZ212492A NZ21249285A NZ212492A NZ 212492 A NZ212492 A NZ 212492A NZ 212492 A NZ212492 A NZ 212492A NZ 21249285 A NZ21249285 A NZ 21249285A NZ 212492 A NZ212492 A NZ 212492A
Authority
NZ
New Zealand
Prior art keywords
spiro
heterocyclic ring
pharmaceutical compositons
epoxy steroids
steroids
Prior art date
Application number
NZ212492A
Other languages
English (en)
Inventor
M Biollaz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ212492A publication Critical patent/NZ212492A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ212492A 1984-06-21 1985-06-20 Epoxy steroids with spiro-heterocyclic ring and pharmaceutical compositons NZ212492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH464684 1984-09-28

Publications (1)

Publication Number Publication Date
NZ212492A true NZ212492A (en) 1989-02-24

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ212492A NZ212492A (en) 1984-06-21 1985-06-20 Epoxy steroids with spiro-heterocyclic ring and pharmaceutical compositons

Country Status (16)

Country Link
US (1) US4670551A (instruction)
EP (1) EP0165902B1 (instruction)
AR (2) AR242036A1 (instruction)
AU (1) AU582754B2 (instruction)
CA (1) CA1239388A (instruction)
DE (1) DE3569540D1 (instruction)
DK (1) DK173854B1 (instruction)
ES (2) ES8704967A1 (instruction)
FI (1) FI83225C (instruction)
GR (1) GR851499B (instruction)
HU (1) HU192232B (instruction)
IE (1) IE58050B1 (instruction)
IL (1) IL75569A (instruction)
NO (1) NO165496C (instruction)
NZ (1) NZ212492A (instruction)
PT (1) PT80663B (instruction)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009176B1 (ru) * 1995-12-11 2007-12-28 Дж.Д.Серл Энд Ко. Способ получения 7-альфа-карбоксил-9,11-эпоксистероидов и промежуточных продуктов, используемых для их получения, и общий способ эпоксидирования по олефиновым двойным связям
ATE375992T1 (de) 1996-12-11 2007-11-15 Searle Llc Epoxidierungsverfahren
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
EP1223174A3 (en) * 1996-12-11 2005-03-16 G.D. Searle & Co. Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
WO2003049745A1 (en) 2001-12-12 2003-06-19 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
EP0134529B1 (de) * 1983-08-17 1990-03-21 Schering Aktiengesellschaft 7-alpha-Substituierte 3-Oxo-17alpha-pregn-4-en-21.17-carbolactone, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
AU4397185A (en) 1986-01-02
PT80663B (en) 1987-05-08
AR242036A1 (es) 1993-02-26
DE3569540D1 (en) 1989-05-24
FI83225C (fi) 1991-06-10
EP0165902A3 (en) 1986-10-22
IL75569A (en) 1989-03-31
DK173854B1 (da) 2001-12-27
DK280085A (da) 1985-12-22
IL75569A0 (en) 1985-10-31
HUT38367A (en) 1986-05-28
NO852501L (no) 1985-12-23
ES544387A0 (es) 1987-04-16
IE58050B1 (en) 1993-06-16
IE851535L (en) 1985-12-21
HU192232B (en) 1987-05-28
NO165496C (no) 1991-02-20
ES8704967A1 (es) 1987-04-16
DK280085D0 (da) 1985-06-20
CA1239388A (en) 1988-07-19
EP0165902A2 (de) 1985-12-27
AR245731A1 (es) 1994-02-28
ES8707737A1 (es) 1987-08-16
NO165496B (no) 1990-11-12
US4670551A (en) 1987-06-02
AU582754B2 (en) 1989-04-13
FI852430L (fi) 1985-12-22
FI852430A0 (fi) 1985-06-19
FI83225B (fi) 1991-02-28
ES557112A0 (es) 1987-08-16
PT80663A (en) 1985-07-01
EP0165902B1 (de) 1989-04-19
GR851499B (instruction) 1985-11-25

Similar Documents

Publication Publication Date Title
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
EP0173990A3 (en) External pharmaceutical composition
PH22863A (en) Pyrrolobenzimidazoles and pharmaceutical composition containing them
IL74758A (en) Acyltripeptides and pharmaceutical compositions containing them
GR861601B (en) Thiazoles their production and pharmaceutical compositions containing them
IL78584A (en) Sealing material and its preparation
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ216678A (en) Heterocyclic substituted-phenoxyalkyl-isoxazoles and -furans and pharmaceutical compositions
AU7430787A (en) Iv tube anchor and shield
DE3571831D1 (en) Epoxy composition and application thereof
NZ212492A (en) Epoxy steroids with spiro-heterocyclic ring and pharmaceutical compositons
NZ212726A (en) Aminophenol derivatives and pharmaceutical compositons
EP0216303A3 (en) External medication
IL75864A (en) Tricyclic dihydroamino-pyridazinones and pharmaceutical compositions containing them and some intermediates therefor
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
ZA853379B (en) Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents
GB2187191B (en) Protection of proteins and the like
DE3565229D1 (en) Mechanical pencil and method of assembling the same
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
DE3565890D1 (en) Mortar and ring therefor
NZ214048A (en) Cephalosporins and pharmaceutical compositions
DE3563624D1 (en) Novel substituted trifluorooxetane and preparation thereof
AU4635885A (en) Compounds for site-enhanced delivery of radionuclides and uses thereof
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same